| [1] |
Ruggeri M, Bianchi E, Rossi S, et al. Nanotechnology-based medical devices for the treatment of chronic skin lesions: From research to the clinic[J]. Pharmaceutics, 2020, 12(9): 815.
|
| [2] |
Nicholas MN, Yeung J. Current status and future of skin substitutes for chronic wound healing[J]. J Cutan Med Surg, 2017, 21(1): 23-30
|
| [3] |
Ferriol A, Morán MDC. Enhanced performance of gelatin 5-fluorouracil-containing nanoparticles against squamous cell carcinoma in simulated chronic wounds conditions[J]. Mater Sci Eng C Mater Biol Appl, 2021, 124: 112073.
|
| [4] |
Khunkaew S, Fernandez R, Sim J. Health-related quality of life among adults living with diabetic foot ulcers: a meta-analysis[J]. Qual Life Res, 2019, 28(6): 1413-1427.
|
| [5] |
Macioch T, Sobol E, Krakowiecki A, et al. Health related quality of life in patients with diabetic foot ulceration - translation and Polish adaptation of Diabetic Foot Ulcer Scale short form[J]. Health Qual Life Outcomes, 2017, 15(1): 15.
|
| [6] |
Banharak S, Panpanit L, Subindee S, et al. Prevention and Care for Incontinence-Associated Dermatitis Among Older Adults: A Systematic Review[J]. J Multidiscip Healthc, 2021, 14: 2983-3004.
|
| [7] |
Juchaux F, Berger S, Bouschbacher M. Effects of Urgotul and Atrauman dressings on human fibroblast viability[N]. Harrogate: Wounds UK, 2009.
|
| [8] |
Winter GD. Formation of the scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig[J]. Nature，1962, 193: 293-294.
|
| [9] |
White R, Cowan T, Glover D. Supporting evidence-based practice: a clinical review of TLC technology[J]. Wound Care, 2011, 20: 1-36.
|
| [10] |
Benbow M, Iosson G. A clinical evaluation of Urgotul to treat acute and chronic wounds[J]. Br J Nurs, 2004, 13(2): 105-109.
|
| [11] |
Broussard KC, Powers JG. Wound dressings: selecting the most appropriate type[J]. Am J Clin Dermatol, 2013, 14(6): 449-459.
|
| [12] |
Nair H, Venkateshwaran N, Seetharaman SS, et al. Benefits of sucrose octasulfate (TLC-NOSF) dressings in the treatment of chronic wounds: a systematic review[J]. J Wound Care, 2021, 30(Sup4): S42-S52.
|
| [13] |
Desroche N, Dropet C, Janod P, et al. Antibacterial properties and reduction of MRSA biofilm with a dressing combining polyabsorbent fibres and a silver matrix[J]. J Wound Care, 2016, 25(10): 577-584.
|
| [14] |
Bainbridge P. Wound healing and the role of fibroblasts[J]. J Wound Care, 2013, 22(8): 407-408, 410-412.
|
| [15] |
Lipp C, Kirker K, Agostinho A, et al. Testing wound dressings using an in vitro wound model[J]. J Wound Care, 2010, 19(6): 220-226.
|
| [16] |
Viennet C, Bride J, Gabiot AC, et al. Comparison of different wound dressings on cultured human fibroblasts and collagen lattices[J]. J Wound Care, 2003, 12(10): 385-390.
|
| [17] |
Bernard FX, Barrault C, Juchaux F, et al. Stimulation of the proliferation of human dermal fibroblasts in vitro by a lipidocolloid dressing[J]. J Wound Care, 2005, 14(5): 215-220.
|
| [18] |
Bernard FX, Juchaux F, Laurensou C. Effects of a lipidocolloid dressing on the production of the extracellular matrix by human dermal fibroblasts in vitro[J]. Physical Chemistry, 2007, 12(58): 9-11.
|
| [19] |
Meaume S, Ourabah Z, Cartier H, et al. Evaluation of a lipidocolloid wound dressing in the local management of leg ulcers[J]. J Wound Care, 2005, 14(7): 329-334.
|
| [20] |
Benbow M, Iosson G. A clinical evaluation of Urgotul to treat acute and chronic wounds[J]. Br J Nurs, 2004, 13(2): 105-109.
|
| [21] |
Blanchet-Bardon C, Bohbot S. Using Urgotul dressing for the management of epidermolysis bullosa skin lesions[J]. Wound Care, 2005, 14(10): 490-491, 494-496.
|
| [22] |
Ma KK, Chan MF, Pang SM. The effectiveness of using a lipido-colloid dressing for patients with traumatic digital wounds[J]. Clin Nurs Res, 2006, 15(2): 119-134.
|
| [23] |
Baek W, Lee N, Han EJ, et al. A Prospective Randomized Study: The Usefulness and Efficacy of Negative Pressure Wound Therapy with Lipidocolloid Polyester Mesh Compared to Traditional Negative Pressure Wound Therapy for Treatment of Pressure Ulcers[J]. Pharmaceutics, 2020, 12(9): 813.
|
| [24] |
Meaume S, Téot L, Lazareth I, et al. The importance of pain reduction through dressing selection in routine wound management: the MAPP study[J].J Wound Care, 2004, 13(10): 409-413.
|
| [25] |
Denyer J, Pillay E, Clapham J. Best practice guidelines: skin and wound care in epidermolysis bullosa 2017[Z/OL]. Wounds International. [2017-05-03].
URL
|
| [26] |
Letouze A, Voinchet V, Hoecht B, et al. Using a new lipidocolloid dressing in paediatric wounds: results of French and German clinical studies[J]. J Wound Care. 2004, 13(6): 221-225.
|
| [27] |
Malmsjö M, Ingemansson R, Martin R, et al. Negative-pressure wound therapy using gauze or open-cell polyurethane foam: similar early effects on pressure transduction and tissue contraction in an experimental porcine wound model[J]. Wound Repair Regen, 2009, 17(2): 200-205.
|
| [28] |
Téot L, Lambert L, Ourabah Z, et al. Use of topical negative pressure with a lipidocolloid dressing: results of a clinical evaluation[J]. J Wound Care, 2006, 15(8): 355-358.
|